Monkeys respond well to Ebola vaccine in study

05/24/2010 | HealthDay News

A vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases appeared to protect cynomolgus macaque monkeys from three strains of the Ebola virus. "This finding will guide future vaccine design and may open an avenue for developing a single vaccine that works against both known and emerging Ebola virus species," said Anthony Fauci, director of the institute.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX